My Quote Request
No products added yet
6505-01-223-0680
20 Products
PERI-D.O.S. SYRUP
DOCUSATE SODIUM AND CASANTHRANOL SYRUP
NSN, MFG P/N
6505012230680
NSN
6505-01-223-0680
PERI-D.O.S. SYRUP
DOCUSATE SODIUM AND CASANTHRANOL SYRUP
NSN, MFG P/N
6505012230680
NSN
6505-01-223-0680
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS CASANTHRANOL PER MILLILITER AND 4.000 MILLIGRAMSDOCUSATE SODIUM PER MILLILITER
ADMINISTRATION: ORAL
FLAVOR: ANY ACCEPTABLE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 16.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00074-7653-07
PERITONEAL DIALYSIS SOLUTION
NSN, MFG P/N
6505012221915
NSN
6505-01-222-1915
NDC00074-7653-07
PERITONEAL DIALYSIS SOLUTION
NSN, MFG P/N
6505012221915
NSN
6505-01-222-1915
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.500 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 25.700 MILLIGRAMS CALCIUM CHLORIDE ACTIVE INGREDIENT AND 15.200 MILLIGRAMS MAGNESIUM CHLORIDE ACTIVE INGREDIENT AND 567.000 MILLIGRAMS SODIUM CHLORIDE ACTIVE INGREDIENT AND 392.000 MILLIGRAMS SODIUM
ADMINISTRATION: INTRAPERITONEAL
PRIMARY CONTAINER CONTENT QUANTITY: 2000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: WITH SYSTEM 3 ADMINISTRATION SET
TOTAL PRIMARY CONTAINER QUANTITY: 6
~1: LACTATE ACTIVE INGREDIENT
Related Searches:
CHOLEDYL
MULTIVITAMIN CAPSULES
NSN, MFG P/N
6505012223120
NSN
6505-01-222-3120
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
CAPSULE CONTENT FORM: TABLET
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ACTIVE MEDICAMENT MEDICINAL STRENGTY:100.000 MILLIGRAMS OF CHOLINE THEOPHYLLINATE ACTIVE INGREDIENTS
Related Searches:
NDC00182-1633-01
MULTIVITAMIN CAPSULES
NSN, MFG P/N
6505012223120
NSN
6505-01-222-3120
NDC00182-1633-01
MULTIVITAMIN CAPSULES
NSN, MFG P/N
6505012223120
NSN
6505-01-222-3120
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
CAPSULE CONTENT FORM: TABLET
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ACTIVE MEDICAMENT MEDICINAL STRENGTY:100.000 MILLIGRAMS OF CHOLINE THEOPHYLLINATE ACTIVE INGREDIENTS
Related Searches:
NDC00264-1129-00
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505012223121
NSN
6505-01-222-3121
NDC00264-1129-00
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505012223121
NSN
6505-01-222-3121
MFG
B BRAUN MEDICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 70.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
S1290
DEXTROSE INJECTION,USP
NSN, MFG P/N
6505012223121
NSN
6505-01-222-3121
MFG
B BRAUN MEDICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 70.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NDC50962-0026-25
DOCUSATE SODIUM SYRUP,USP
NSN, MFG P/N
6505012223559
NSN
6505-01-222-3559
NDC50962-0026-25
DOCUSATE SODIUM SYRUP,USP
NSN, MFG P/N
6505012223559
NSN
6505-01-222-3559
MFG
HOWMET CORP WHITEHALL CASTING DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS DIOCTYL SODIUM SULFOSUCCINATE PER MILLILITER
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 MILLILITERS
PRIMARY CONTAINER TYPE: CUP, UNIT DOSE
SPECIAL FEATURES: 25 ML. FILL IN 45 ML. PATIENT CUP
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
NDC51079-0640-30
DOCUSATE SODIUM SYRUP,USP
NSN, MFG P/N
6505012223559
NSN
6505-01-222-3559
NDC51079-0640-30
DOCUSATE SODIUM SYRUP,USP
NSN, MFG P/N
6505012223559
NSN
6505-01-222-3559
MFG
UDL LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.000 MILLIGRAMS DIOCTYL SODIUM SULFOSUCCINATE PER MILLILITER
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 MILLILITERS
PRIMARY CONTAINER TYPE: CUP, UNIT DOSE
SPECIAL FEATURES: 25 ML. FILL IN 45 ML. PATIENT CUP
TOTAL PRIMARY CONTAINER QUANTITY: 100
Related Searches:
NDC00108-5014-10
CIMETIDINE HYDROCHLORIDE ORAL SOLUTION
NSN, MFG P/N
6505012223560
NSN
6505-01-222-3560
NDC00108-5014-10
CIMETIDINE HYDROCHLORIDE ORAL SOLUTION
NSN, MFG P/N
6505012223560
NSN
6505-01-222-3560
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS CIMETIDINE EQUIVALENT PER 5 MILLILITERS
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CIMETIDINE HYDROCHLORIDE ORAL SOLUTION 60MG/ML 5ML TUBE 10S
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: ANY ACCEPTABLE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
TAGAMET
CIMETIDINE HYDROCHLORIDE ORAL SOLUTION
NSN, MFG P/N
6505012223560
NSN
6505-01-222-3560
TAGAMET
CIMETIDINE HYDROCHLORIDE ORAL SOLUTION
NSN, MFG P/N
6505012223560
NSN
6505-01-222-3560
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS CIMETIDINE EQUIVALENT PER 5 MILLILITERS
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CIMETIDINE HYDROCHLORIDE ORAL SOLUTION 60MG/ML 5ML TUBE 10S
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: ANY ACCEPTABLE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
TAGAMET LIQUID
CIMETIDINE HYDROCHLORIDE ORAL SOLUTION
NSN, MFG P/N
6505012223560
NSN
6505-01-222-3560
TAGAMET LIQUID
CIMETIDINE HYDROCHLORIDE ORAL SOLUTION
NSN, MFG P/N
6505012223560
NSN
6505-01-222-3560
MFG
GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS CIMETIDINE EQUIVALENT PER 5 MILLILITERS
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CIMETIDINE HYDROCHLORIDE ORAL SOLUTION 60MG/ML 5ML TUBE 10S
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: ANY ACCEPTABLE
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00781-7160-16
LINDANE SHAMPOO,USP
NSN, MFG P/N
6505012223911
NSN
6505-01-222-3911
MFG
GENEVA PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, V/V LINDANE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LINDANE SHAMPOO USP NONMEDICATED 1 PINT BOTTLE
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 PINTS
PRIMARY CONTAINER TYPE: BOTTLE, GLASS
Related Searches:
NDC60432-0547-16
LINDANE SHAMPOO,USP
NSN, MFG P/N
6505012223911
NSN
6505-01-222-3911
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 PERCENTAGE, V/V LINDANE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LINDANE SHAMPOO USP NONMEDICATED 1 PINT BOTTLE
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 PINTS
PRIMARY CONTAINER TYPE: BOTTLE, GLASS
Related Searches:
NDC00074-7673-09
AMINO ACIDS AND DETROSE SOLUTIONS FOR INJECTION
NSN, MFG P/N
6505012226454
NSN
6505-01-222-6454
NDC00074-7673-09
AMINO ACIDS AND DETROSE SOLUTIONS FOR INJECTION
NSN, MFG P/N
6505012226454
NSN
6505-01-222-6454
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: ANY ACCEPTABLE
SPECIAL FEATURES: SINGLE-DOSE; DUAL-CHAMBERED FLEXIBLE PLASTIC CONTAINER W/3 OUTLET PORTS IN OVERPOUCH W/HEAVY GAUGE PLASTIC HANGER STRAP SLOTTED IN CENTER; UPPER CHAMBER 500 ML OF 7 PCT W/V CRYSTALLINE AMINO ACIDS INJECTION,LOWER CHAMBER - 500 ML OF 50 PCT W/V DEXTROSE
TOTAL PRIMARY CONTAINER QUANTITY: 6
~1: INJECTION; CHAMBERS SHALL BE SEPARATED BY REMOVABLE CLAMP; AFTER MIXING: 3.5 PCT W/V AMINO ACIDS AND 25 PCT W/V DEXTROSE IN 1000 ML; LEAKPROOF; F/USE W/IV ADMINISTRATION SETS 6515-00-185-5158,6515-00-484-0484,6515-01-08
~2: 2-1021,6515-00-115-0032,6515-00-140-0888,6515-01-105-0614,6515-01-153-4703,AND 6515-01-153-5669
Related Searches:
NUTRIMIX
AMINO ACIDS AND DETROSE SOLUTIONS FOR INJECTION
NSN, MFG P/N
6505012226454
NSN
6505-01-222-6454
NUTRIMIX
AMINO ACIDS AND DETROSE SOLUTIONS FOR INJECTION
NSN, MFG P/N
6505012226454
NSN
6505-01-222-6454
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: ANY ACCEPTABLE
SPECIAL FEATURES: SINGLE-DOSE; DUAL-CHAMBERED FLEXIBLE PLASTIC CONTAINER W/3 OUTLET PORTS IN OVERPOUCH W/HEAVY GAUGE PLASTIC HANGER STRAP SLOTTED IN CENTER; UPPER CHAMBER 500 ML OF 7 PCT W/V CRYSTALLINE AMINO ACIDS INJECTION,LOWER CHAMBER - 500 ML OF 50 PCT W/V DEXTROSE
TOTAL PRIMARY CONTAINER QUANTITY: 6
~1: INJECTION; CHAMBERS SHALL BE SEPARATED BY REMOVABLE CLAMP; AFTER MIXING: 3.5 PCT W/V AMINO ACIDS AND 25 PCT W/V DEXTROSE IN 1000 ML; LEAKPROOF; F/USE W/IV ADMINISTRATION SETS 6515-00-185-5158,6515-00-484-0484,6515-01-08
~2: 2-1021,6515-00-115-0032,6515-00-140-0888,6515-01-105-0614,6515-01-153-4703,AND 6515-01-153-5669
Related Searches:
NDC00014-1011-52
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505012226567
NSN
6505-01-222-6567
NDC00014-1011-52
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505012226567
NSN
6505-01-222-6567
MFG
SEARLE G D AND CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS SPIRONOLACTONE ACTIVE INGREDIENT AND 25.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00555-0265-05
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505012226567
NSN
6505-01-222-6567
NDC00555-0265-05
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505012226567
NSN
6505-01-222-6567
MFG
BARR PHARMACEUTICALS LLC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS SPIRONOLACTONE ACTIVE INGREDIENT AND 25.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00725-0129-10
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505012226567
NSN
6505-01-222-6567
NDC00725-0129-10
SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505012226567
NSN
6505-01-222-6567
MFG
CIRCA PHARMACEUTICAL CO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 25.000 MILLIGRAMS SPIRONOLACTONE ACTIVE INGREDIENT AND 25.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00536-0840-85
GUAIFENESIN AND CODEINE PHOSPHATE SYRUP
NSN, MFG P/N
6505012226568
NSN
6505-01-222-6568
NDC00536-0840-85
GUAIFENESIN AND CODEINE PHOSPHATE SYRUP
NSN, MFG P/N
6505012226568
NSN
6505-01-222-6568
MFG
CHELSEA LABORATORIES INC DIV OF RUGBY LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS CODEINE PHOSPHATE PER MILLILITER AND 20.000 MILLIGRAMS GUAIFENESIN PER MILLILITER
III CONTROLLED SUBSTANCE CLASSIFICATION: SCHEDULE V
III PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
PHARMACEUTICAL VEHICLE TYPE: ALCOHOLIC
PRIMARY CONTAINER CONTENT QUANTITY: 16.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ALCOHOL CONTENT IS 3.5%
Related Searches:
NDC00182-0933-40
DOCUSATE SODIUM AND CASANTHRANOL SYRUP
NSN, MFG P/N
6505012230680
NSN
6505-01-223-0680
NDC00182-0933-40
DOCUSATE SODIUM AND CASANTHRANOL SYRUP
NSN, MFG P/N
6505012230680
NSN
6505-01-223-0680
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS CASANTHRANOL PER MILLILITER AND 4.000 MILLIGRAMSDOCUSATE SODIUM PER MILLILITER
ADMINISTRATION: ORAL
FLAVOR: ANY ACCEPTABLE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 16.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
